Post by University of Washington Bioengineering

Connor Krolak's dissertation defense will be Thursday, May 14, at 10 am in N130 Foege Hall, and the public is invited to attend. Krolak studies contrast-enhanced ultrasound with Professor Mike Averkiou to make liver cancer diagnosis and treatment accessible to more people, especially those in remote settings, using tools available in most hospitals. Ultrasound and Microbubbles: Modulating and Quantifying Blood Flow in Liver Cancers Connor Krolak May 14, 10 am Watch online: https://lnkd.in/ghrdZgTv "I first established how repeatable tumor blood flow evaluations can be with CEUS, to help identify when a true change in blood flow happens and determine if the patient is responding to their drug treatment. I then developed an algorithm to quantify tumor blood flow, aiming to assist with earlier detection and diagnosis of hepatocellular carcinoma to improve patient outcomes. Finally, I explored how therapeutic CEUS could be used to alter tumor blood flow and enhance drug delivery in a mouse model of the cancer, to make current chemotherapy more effective at lower and more tolerable doses," Krolak said.